Beyond Transfusion: The Rise of Artificial Blood Technologies
Recent research in Annals of Blood (March 2026) highlights a shift in artificial blood development from experimental studies to clinically relevant oxygen therapeutics. The review notes that artificial blood aims to address key limitations of donor blood, including supply shortages, storage issues, and compatibility issues. These products offer immediate availability without cross-matching, reduced infectious risk,…
Read
Off-Pump CABG in 2026: Outcome Gains Driven by Experience and Patient Selection
Analysis of 2026 data from the Society of Thoracic Surgeons database, encompassing over 1.5 million coronary artery bypass grafting (CABG) cases, indicates that off-pump CABG (OPCAB) is associated with substantial reductions in early complications. Compared with on-pump CABG, OPCAB demonstrated approximately 10–20% lower operative mortality, a 15–30% reduction in stroke incidence, and notable reductions in…
Read
Rethinking Anticoagulation in ECMO
Tianyu Zhang and colleagues recently published a systematic review and meta-analysis in Frontiers in Medicine evaluating reduced-intensity and heparin-sparing anticoagulation strategies during Extracorporeal Membrane Oxygenation (ECMO). Systemic anticoagulation with unfractionated heparin has traditionally represented the standard of care in ECMO management; however, bleeding complications continue to pose a significant challenge. The study aimed to determine…
Read
Clinical News
Perfusion Times provides news on innovative technologies from everything to clinical trials to how to use and process medical data. We provide information and insights on innovation between clinical trial management and best practices for patient care.
-
Beyond Transfusion: The Rise of Artificial Blood Technologies
-
Off-Pump CABG in 2026: Outcome Gains Driven by Experience and Patient Selection
-
Rethinking Anticoagulation in ECMO
-
Myocardial Microcirculation Combined With Lactate Predicts LV Function After DCD Heart Transplantation
-
Normothermic Regional Perfusion as a Platform for DCD Lung Assessment and Recovery
Medical Device Industry News
Perfusion Times is your direct source for information on the latest medical device products, covering everything involved in the supply chain from biomaterials and materials solutions to electronic devices, medical packaging, motors, and more!
-
AngioVac-Assisted Debulking before Lead Extraction in Device-Related Endocarditis
-
New Cardiac Assist Technology Proven Accurate Through Advanced Simulation
-
FDA Recognizes SeaStar Medical’s SCD as Breakthrough Device for Managing Systemic Inflammation
-
Evaluating Cannula Performance in Pediatric ECMO: Pulsatile vs. Non-Pulsatile Flow Insights
-
Renal Transplant Perfusion through Strategic Patient Positioning
FDA Announcements
Perfusion Times provides up-to-date FDA news releases related to perfusion to ensure you’re educated to follow regulatory requirements in your practice.
-
FDA Approves Aficamten (Myqorzo) for Symptomatic Obstructive Hypertrophic Cardiomyopathy
-
Robotic-Assisted Mitral and Revascularization Procedures: Expanded FDA Clearance for da Vinci 5
-
FDA Expands Indication for Medtronic Evolut™ TAVR Systems
-
BiVACOR’s Total Artificial Heart Earns FDA Breakthrough Status
-
A Wearable Lifeline: FDA Clears Jewel Patch Defibrillator for At-Risk Patients
Healthcare & Economics
Perfusion Times provides best practices on information such as patient charting, data analysis, inventory entry, and more! This also covers managing planning, reporting and analytics to ensure you always have up to date information to care for and have better patient outcomes. Some of the specific topics we cover include cardiopulmonary bypass and support services, autotransfusion and platelet gel services, extracorporeal membrane oxygenation (ECMO) services, chemoperfusion, and database management and legal and professional consultation.
-
Perspectives on Acute Decompensated RV Failure in Pulmonary Arterial Hypertension
-
The Influence of Cardiopulmonary Bypass Duration on Mortality and Mid-Term Survival in Acute Type A Aortic Dissection Repair
-
Advances and Clinical Insights in Cardiac Surgery 2024: A Comprehensive Review of Evidence and Outcomes
-
Study Confirms No Brain Activity During TA-NRP with Supra-Aortic Vessel Ligation
-
Perfusion Optimization and Lactate Dynamics in Normothermic Regional Perfusion A Summary of the 2025 Baylor Experience